Tolerance	O
to	O
lipopolysaccharide	O
involves	O
mobilization	O
of	O
nuclear	B-protein
factor	I-protein
kappa	I-protein
B	I-protein
with	O
predominance	O
of	O
p50	B-protein
homodimers	O
.	O

Stimulation	O
of	O
the	O
human	B-cell_line
monocytic	I-cell_line
cell	I-cell_line
line	I-cell_line
Mono	B-cell_line
Mac	I-cell_line
6	I-cell_line
with	O
lipopolysaccharide	O
(	O
LPS	O
)	O
leads	O
to	O
rapid	O
and	O
transient	O
expression	O
of	O
cytokines	B-protein
like	O
tumor	B-protein
necrosis	I-protein
factor	I-protein
(	O
TNF	B-protein
)	O
.	O

When	O
such	O
cells	O
are	O
precultured	O
for	O
2	O
days	O
with	O
a	O
low	O
dose	O
of	O
LPS	O
(	O
20	O
ng/ml	O
)	O
followed	O
by	O
stimulation	O
with	O
a	O
high	O
dose	O
of	O
LPS	O
(	O
1	O
microgram/ml	O
)	O
,	O
expression	O
of	O
the	O
TNF	B-DNA
gene	I-DNA
is	O
minimal	O
,	O
i.e.	O
the	O
cells	O
are	O
tolerant	O
.	O

In	O
nuclear	O
run-on	O
analysis	O
,	O
such	O
tolerant	B-cell_type
cells	I-cell_type
show	O
only	O
a	O
low	O
degree	O
of	O
transcription	O
,	O
indicating	O
that	O
tolerance	O
operates	O
at	O
or	O
upstream	O
of	O
the	O
transcription	O
level	O
.	O

The	O
CD14	B-protein
LPS	O
receptor	O
is	O
,	O
however	O
,	O
up-regulated	O
(	O
not	O
down-regulated	O
)	O
in	O
tolerant	B-cell_line
cells	I-cell_line
,	O
and	O
LPS	O
can	O
,	O
in	O
fact	O
,	O
still	O
lead	O
to	O
activation	O
of	O
tolerant	B-cell_line
cells	I-cell_line
as	O
evidenced	O
by	O
mobilization	O
of	O
the	O
transcription	B-protein
factor	I-protein
nuclear	B-protein
factor	I-protein
kappa	I-protein
B	I-protein
(	O
NF-kappa	B-protein
B	I-protein
)	O
.	O

Resolution	O
of	O
the	O
NF-kappa	B-protein
B	I-protein
complex	I-protein
in	O
gel	O
shift	O
analysis	O
shows	O
that	O
the	O
binding	B-protein
protein	I-protein
,	O
mobilized	O
in	O
naive	B-cell_line
Mono	I-cell_line
Mac	I-cell_line
6	I-cell_line
cells	I-cell_line
,	O
consists	O
mainly	O
of	O
p50-p65	B-protein
heterodimers	I-protein
,	O
while	O
in	O
tolerant	B-cell_line
cells	I-cell_line
,	O
the	O
p50	B-protein
homodimer	I-protein
is	O
predominant	O
.	O

This	O
increase	O
in	O
p50	B-protein
homodimers	I-protein
coincides	O
with	O
an	O
increase	O
in	O
p105	B-RNA
mRNA	I-RNA
,	O
suggestive	O
of	O
a	O
transcriptional	O
up-regulation	O
of	O
p50	B-protein
.	O

Reporter	O
gene	O
analysis	O
reveals	O
that	O
the	O
NF-kappa	B-protein
B	I-protein
complex	I-protein
mobilized	O
in	O
tolerant	B-cell_line
cells	I-cell_line
is	O
functionally	O
inactive	O
in	O
that	O
NF-kappa	B-DNA
B-dependent	I-DNA
luciferase	I-DNA
constructs	I-DNA
containing	O
the	O
human	B-DNA
immunodeficiency	I-DNA
virus	I-DNA
long	I-DNA
terminal	I-DNA
repeat	I-DNA
or	O
the	O
TNF	B-DNA
5'-region	I-DNA
show	O
only	O
minimal	O
transactivation	O
after	O
LPS	O
stimulation	O
.	O

Similar	O
to	O
Mono	B-cell_line
Mac	I-cell_line
6	I-cell_line
cells	I-cell_line
,	O
primary	B-cell_type
blood	I-cell_type
monocytes	I-cell_type
,	O
when	O
precultured	O
with	O
a	O
low	O
dose	O
of	O
LPS	O
,	O
also	O
become	O
tolerant	O
and	O
produce	O
little	O
TNF	B-protein
after	O
LPS	O
stimulation	O
.	O

The	O
tolerant	B-cell_type
blood	I-cell_type
monocytes	I-cell_type
also	O
up-regulate	O
CD14	B-protein
,	O
and	O
they	O
mobilize	O
NF-kappa	B-protein
B	I-protein
with	O
a	O
predominance	O
of	O
p50	B-protein
homodimers	I-protein
.	O

Taken	O
together	O
,	O
these	O
results	O
demonstrate	O
that	O
tolerance	O
to	O
LPS	O
is	O
determined	O
by	O
post-receptor	O
mechanisms	O
that	O
involve	O
an	O
altered	O
composition	O
of	O
the	O
NF-kappa	B-protein
B	I-protein
complex	I-protein
.	O

Communication	NULL
Tolerance	NULL
to	NULL
Lipopolysaccharide	NULL
Involves	NULL
Mobilization	NULL
of	NULL
Nuclear	NULL
Factor	NULL
«	NULL
B	NULL
with	NULL
Predominance	NULL
of	NULL
p50	NULL
Homodimers*	NULL
(	NULL
Received	NULL
for	NULL
publication	NULL
,	NULL
April	NULL
15	NULL
,	NULL
1994	NULL
,	NULL
and	NULL
in	NULL
revised	NULL
form	NULL
,	NULL
April	NULL
28	NULL
,	NULL
1994	NULL
)	NULL
H.	NULL
W.	NULL
Loms	NULL
Ziegler-Heitbrock	NULL
?	NULL
}	NULL

§	NULL
,	NULL
Angela	NULL
Wedelt	NULL
,	NULL
Winfried	NULL
Schrautt	NULL
,	NULL
Marion	NULL
Strobel+	NULL
,	NULL
Petra	NULL
Thomas	NULL
Sternsdorf	NULL
?	NULL

,	NULL
Patrick	NULL
A	NULL
.	NULL

Biuerle	NULL
?	NULL
]	NULL

,	NULL
Jiirgen	NULL
G.	NULL
Haas	NULL
#	NULL
]	NULL
,	NULL
and	NULL
Gert	NULL
Riethmiillert	NULL
From	NULL
the	NULL
{	NULL
Institute	NULL
for	NULL
Immunology	NULL
,	NULL
Goethestrasse	NULL
31	NULL
,	NULL
80336	NULL
Miinchen	NULL
and	NULL
the	NULL
Unstitute	NULL
for	NULL
Biochemistry	NULL
,	NULL
University	NULL
of	NULL
Freiburg	NULL
,	NULL
Hermann-Herder-Strasse	NULL
7	NULL
,	NULL
79104	NULL
Freiburg	NULL
,	NULL
Federal	NULL
Republic	NULL
of	NULL
Germany	NULL
Stimulation	NULL
of	NULL
the	NULL
human	NULL
monocytic	NULL
cell	NULL
line	NULL
Mono	NULL
Mac	NULL
6	NULL
with	NULL
lipopolysaccharide	NULL
(	NULL
LPS	NULL
)	NULL
leads	NULL
to	NULL
rapid	NULL
and	NULL
transient	NULL
expression	NULL
of	NULL
cytokines	NULL
like	NULL
tumor	NULL
necrosis	NULL
factor	NULL
(	NULL
TNF	NULL
)	NULL
.	NULL

When	NULL
such	NULL
cells	NULL
are	NULL
precultured	NULL
for	NULL
2	NULL
days	NULL
with	NULL
a	NULL
low	NULL
dose	NULL
of	NULL
LPS	NULL
(	NULL
20	NULL
ng/ml	NULL
)	NULL
followed	NULL
by	NULL
stimulation	NULL
with	NULL
a	NULL
high	NULL
dose	NULL
of	NULL
LPS	NULL
(	NULL
1	NULL
ug/ml	NULL
)	NULL
,	NULL
expression	NULL
of	NULL
the	NULL
TNF	NULL
gene	NULL
is	NULL
minimal	NULL
,	NULL
i.e	NULL
.	NULL

the	NULL
cells	NULL
are	NULL
toler-ant	NULL
.	NULL

In	NULL
nuclear	NULL
run-on	NULL
analysis	NULL
,	NULL
such	NULL
tolerant	NULL
cells	NULL
show	NULL
only	NULL
a	NULL
low	NULL
degree	NULL
of	NULL
transcription	NULL
,	NULL
indicating	NULL
that	NULL
tolerance	NULL
operates	NULL
at	NULL
or	NULL
upstream	NULL
of	NULL
the	NULL
transcription	NULL
level	NULL
.	NULL

The	NULL
CD14	NULL
LPS	NULL
receptor	NULL
is	NULL
,	NULL
however	NULL
,	NULL
up-regulated	NULL
(	NULL
not	NULL
down-regulated	NULL
)	NULL
in	NULL
tolerant	NULL
cells	NULL
,	NULL
and	NULL
LPS	NULL
can	NULL
,	NULL
in	NULL
fact	NULL
,	NULL
still	NULL
lead	NULL
to	NULL
activation	NULL
of	NULL
tolerant	NULL
cells	NULL
as	NULL
evidenced	NULL
by	NULL
mobilization	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
nuclear	NULL
factor	NULL
«	NULL
B	NULL
(	NULL
NF-	NULL
«	NULL
B	NULL
)	NULL
.	NULL

Resolution	NULL
of	NULL
the	NULL
NF-KB	NULL
complex	NULL
in	NULL
gel	NULL
shift	NULL
analysis	NULL
shows	NULL
that	NULL
the	NULL
binding	NULL
protein	NULL
,	NULL
mobilized	NULL
in	NULL
naive	NULL
Mono	NULL
Mac	NULL
6	NULL
cells	NULL
,	NULL
consists	NULL
mainly	NULL
of	NULL
p50-p65	NULL
heterodimers	NULL
,	NULL
while	NULL
in	NULL
tolerant	NULL
cells	NULL
,	NULL
the	NULL
p50	NULL
homodimer	NULL
is	NULL
predominant	NULL
.	NULL

This	NULL
increase	NULL
in	NULL
p50	NULL
homodimers	NULL
coincides	NULL
with	NULL
an	NULL
increase	NULL
in	NULL
p1l05	NULL
mRNA	NULL
,	NULL
suggestive	NULL
of	NULL
a	NULL
transcriptional	NULL
up-regulation	NULL
of	NULL
p50	NULL
.	NULL

Reporter	NULL
gene	NULL
analysis	NULL
reveals	NULL
that	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
complex	NULL
mobilized	NULL
in	NULL
tolerant	NULL
cells	NULL
is	NULL
functionally	NULL
inactive	NULL
in	NULL
that	NULL
NF-	NULL
«	NULL
B-dependent	NULL
luciferase	NULL
constructs	NULL
containing	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
long	NULL
terminal	NULL
repeat	NULL
or	NULL
the	NULL
TNF	NULL
5'-region	NULL
show	NULL
only	NULL
minimal	NULL
transactivation	NULL
after	NULL
LPS	NULL
stimulation	NULL
.	NULL

Similar	NULL
to	NULL
Mono	NULL
Mac	NULL
6	NULL
cells	NULL
,	NULL
primary	NULL
blood	NULL
monocytes	NULL
,	NULL
when	NULL
precultured	NULL
with	NULL
a	NULL
low	NULL
dose	NULL
of	NULL
LPS	NULL
,	NULL
also	NULL
become	NULL
tolerant	NULL
and	NULL
produce	NULL
little	NULL
TNF	NULL
after	NULL
LPS	NULL
stimulation	NULL
.	NULL

The	NULL
tolerant	NULL
blood	NULL
monocytes	NULL
also	NULL
up-regulate	NULL
CD14	NULL
,	NULL
and	NULL
they	NULL
mobilize	NULL
NF-	NULL
«	NULL
B	NULL
with	NULL
a	NULL
predominance	NULL
of	NULL
p50	NULL
homodimers	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
results	NULL
demonstrate	NULL
that	NULL
tolerance	NULL
to	NULL
LPS	NULL
is	NULL
determined	NULL
by	NULL
post-receptor	NULL
mechanisms	NULL
*This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
grants	NULL
from	NULL
the	NULL
Wilhelm-Sander-Stiftung	NULL
and	NULL
Thyssen-Stiftung	NULL
and	NULL
by	NULL
Deutsche	NULL
Forschungsgemein-schaft	NULL
SFB	NULL
217	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

§	NULL
To	NULL
whom	NULL
correspondence	NULL
should	NULL
be	NULL
addressed	NULL
.	NULL

Tel./Fax	NULL
:	NULL
49-89-5996-680	NULL
.	NULL

|	NULL
Present	NULL
address	NULL
:	NULL
Dept	NULL
.	NULL

of	NULL
Molecular	NULL
Biology	NULL
,	NULL
Massachusetts	NULL
General	NULL
Hospital	NULL
,	NULL
Boston	NULL
,	NULL
MA	NULL
02114	NULL
.	NULL

THz	NULL
Journat	NULL
or	NULL
Biorocicat	NULL
,	NULL
Vol	NULL
.	NULL

269	NULL
,	NULL
No	NULL
.	NULL

25	NULL
,	NULL
Issue	NULL
of	NULL
June	NULL
24	NULL
,	NULL
pp	NULL
.	NULL

17001-17004	NULL
,	NULL
1994	NULL
©	NULL
1994	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
for	NULL
Biochemistry	NULL
and	NULL
Molecular	NULL
Biology	NULL
,	NULL
Inc	NULL
.	NULL

Printed	NULL
in	NULL
U.S.A.	NULL
that	NULL
involve	NULL
an	NULL
altered	NULL
composition	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
complex	NULL
.	NULL

Repeated	NULL
stimulation	NULL
of	NULL
cells	NULL
can	NULL
result	NULL
in	NULL
loss	NULL
of	NULL
responses	NULL
,	NULL
a	NULL
process	NULL
termed	NULL
desensitization	NULL
or	NULL
tolerance	NULL
.	NULL

Tolerance	NULL
is	NULL
typically	NULL
observed	NULL
for	NULL
B-adrenergic	NULL
drugs	NULL
,	NULL
which	NULL
lose	NULL
activity	NULL
because	NULL
their	NULL
receptors	NULL
disappear	NULL
from	NULL
the	NULL
cell	NULL
surface	NULL
or	NULL
because	NULL
the	NULL
receptors	NULL
are	NULL
uncoupled	NULL
from	NULL
the	NULL
downstream	NULL
signaling	NULL
cascade	NULL
(	NULL
1	NULL
)	NULL
.	NULL

We	NULL
have	NULL
studied	NULL
tolerance	NULL
to	NULL
lipopolysaccharide	NULL
(	NULL
LPS	NULL
'	NULL
;	NULL
endotoxin	NULL
)	NULL
,	NULL
a	NULL
cell	NULL
wall	NULL
constituent	NULL
of	NULL
Gram-negative	NULL
bacteria	NULL
that	NULL
is	NULL
a	NULL
main	NULL
activator	NULL
in	NULL
septic	NULL
shock	NULL
.	NULL

LPS	NULL
acts	NULL
through	NULL
stimulation	NULL
of	NULL
monocytes	NULL
,	NULL
which	NULL
respond	NULL
with	NULL
a	NULL
rapid	NULL
and	NULL
transient	NULL
production	NULL
of	NULL
cytokines	NULL
like	NULL
tumor	NULL
necrosis	NULL
factor	NULL
(	NULL
TNF	NULL
)	NULL
.	NULL

Tolerance	NULL
of	NULL
monocytes/macrophages	NULL
to	NULL
stimulation	NULL
by	NULL
LPS	NULL
has	NULL
long	NULL
been	NULL
known	NULL
from	NULL
studies	NULL
on	NULL
pyrogenicity	NULL
,	NULL
antitumor	NULL
activity	NULL
,	NULL
and	NULL
cytokine	NULL
production	NULL
(	NULL
2-5	NULL
)	NULL
,	NULL
but	NULL
the	NULL
molecular	NULL
mechanism	NULL
has	NULL
remained	NULL
elusive	NULL
.	NULL

We	NULL
now	NULL
show	NULL
that	NULL
receptor	NULL
modulation	NULL
or	NULL
uncoupling	NULL
is	NULL
not	NULL
involved	NULL
.	NULL

Rather	NULL
,	NULL
in	NULL
tolerant	NULL
cells	NULL
,	NULL
the	NULL
CD14	NULL
LPS	NULL
receptor	NULL
is	NULL
up-regulated	NULL
and	NULL
can	NULL
mediate	NULL
mobilization	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

The	NULL
NF-	NULL
«	NULL
B	NULL
complex	NULL
,	NULL
however	NULL
,	NULL
exhibits	NULL
a	NULL
predominance	NULL
of	NULL
the	NULL
p50	NULL
homodimer	NULL
,	NULL
which	NULL
lacks	NULL
transactivation	NULL
activity	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Cells-The	NULL
cell	NULL
line	NULL
Mono	NULL
Mac	NULL
6	NULL
(	NULL
6	NULL
)	NULL
was	NULL
cultured	NULL
in	NULL
24-well	NULL
plates	NULL
at	NULL
2	NULL
x	NULL
10°	NULL
%	NULL
/ml	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
and	NULL
additives	NULL
as	NULL
described	NULL
(	NULL
6	NULL
)	NULL
.	NULL

For	NULL
culture	NULL
of	NULL
human	NULL
blood	NULL
monocytes	NULL
,	NULL
we	NULL
isolated	NULL
peripheral	NULL
blood	NULL
mononuclear	NULL
cells	NULL
by	NULL
density	NULL
gradient	NULL
separa-tion	NULL
.	NULL

For	NULL
tolerance	NULL
induction	NULL
,	NULL
cells	NULL
were	NULL
cultured	NULL
for	NULL
2	NULL
days	NULL
with	NULL
LPS	NULL
from	NULL
Salmonella	NULL
minnesota	NULL
(	NULL
L6261	NULL
,	NULL
Sigma	NULL
,	NULL
Munich	NULL
,	NULL
Germany	NULL
)	NULL
at	NULL
20-50	NULL
ng/ml	NULL
.	NULL

Then	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
washed	NULL
and	NULL
stimulated	NULL
for	NULL
up	NULL
to	NULL
4	NULL
h	NULL
with	NULL
LPS	NULL
at	NULL
1	NULL
pg/ml	NULL
.	NULL

Immunofluorescence-Cells	NULL
were	NULL
stained	NULL
on	NULL
ice	NULL
at	NULL
saturating	NULL
concentrations	NULL
with	NULL
the	NULL
anti-CD14	NULL
monoclonal	NULL
antibody	NULL
My4-fluorescein	NULL
iso-thiocyanate	NULL
conjugate	NULL
or	NULL
isotype	NULL
control	NULL
(	NULL
both	NULL
from	NULL
Coulter	NULL
Electronics	NULL
,	NULL
Krefeld	NULL
,	NULL
Germany	NULL
)	NULL
.	NULL

After	NULL
washing	NULL
,	NULL
5000	NULL
cells/sample	NULL
were	NULL
analyzed	NULL
in	NULL
an	NULL
EPICS	NULL
V	NULL
flow	NULL
cytometer	NULL
(	NULL
Coulter	NULL
Electronics	NULL
)	NULL
.	NULL

TNF	NULL
Bioassay-TNF	NULL
was	NULL
determined	NULL
as	NULL
described	NULL
(	NULL
7	NULL
)	NULL
.	NULL

In	NULL
brief	NULL
,	NULL
supernatants	NULL
of	NULL
stimulated	NULL
cells	NULL
were	NULL
added	NULL
in	NULL
2-fold	NULL
serial	NULL
dilutions	NULL
to	NULL
actinomycin	NULL
D-treated	NULL
WEHI	NULL
164	NULL
murine	NULL
fibrosarcoma	NULL
cells	NULL
in	NULL
96-well	NULL
microtiter	NULL
plates	NULL
.	NULL

After	NULL
overnight	NULL
culture	NULL
,	NULL
viability	NULL
was	NULL
assessed	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
tetrazolium	NULL
salt	NULL
(	NULL
3-	NULL
(	NULL
4,5-dimethylthiazol-2-yl	NULL
)	NULL
-2,5-diphen-yltetrazolium	NULL
bromide	NULL
,	NULL
M2128	NULL
,	NULL
Sigma	NULL
)	NULL
.	NULL

TNF	NULL
activity	NULL
was	NULL
determined	NULL
with	NULL
reference	NULL
to	NULL
a	NULL
recombinant	NULL
standard	NULL
at	NULL
7.4	NULL
x	NULL
10°	NULL
units/mg	NULL
(	NULL
kindly	NULL
provided	NULL
by	NULL
Dr.	NULL
T.	NULL
Subkowski	NULL
,	NULL
BASF	NULL
,	NULL
Ludwigshafen	NULL
,	NULL
Germany	NULL
)	NULL
.	NULL

Northern	NULL
Blot	NULL
Analysis-For	NULL
Northern	NULL
blot	NULL
analysis	NULL
,	NULL
cells	NULL
were	NULL
lysed	NULL
with	NULL
guanidine	NULL
isothiocyanate	NULL
,	NULL
and	NULL
RNA	NULL
was	NULL
purified	NULL
over	NULL
CsCl	NULL
according	NULL
to	NULL
Chirgwin	NULL
et	NULL
al	NULL
.	NULL

(	NULL
8	NULL
)	NULL
.	NULL

10	NULL
ug	NULL
of	NULL
RNA/lane	NULL
was	NULL
applied	NULL
to	NULL
formalde-hyde-agarose	NULL
gels	NULL
,	NULL
and	NULL
after	NULL
electrophoresis	NULL
and	NULL
blotting	NULL
,	NULL
the	NULL
blots	NULL
were	NULL
hybridized	NULL
with	NULL
synthetic	NULL
oligonucleotides	NULL
that	NULL
were	NULL
P-labeled	NULL
by	NULL
poly	NULL
(	NULL
A	NULL
)	NULL
tailing	NULL
.	NULL

The	NULL
oligonucleotides	NULL
used	NULL
were	NULL
as	NULL
follows	NULL
:	NULL
for	NULL
TNF	NULL
,	NULL
5-GGTCTGGTAGGAGACGGCGATGCGGCTGATGGTGTGGGTGA-GGAGCACATGGGTGGAGGG-3	NULL
'	NULL
;	NULL
for	NULL
CD14	NULL
,	NULL
5'-CCAGTCGGGCTGAG-GTTCGGAGAAGTTGCAGACGCAGCGGAAATCTTC-3	NULL
'	NULL
;	NULL
for	NULL
p105	NULL
,	NULL
5'-AGTATACCCAGGTTTGCGAAGCCGACCACCATGACCTTGGGTC-CAGCA-3	NULL
'	NULL
;	NULL
and	NULL
for	NULL
p65	NULL
,	NULL
5-AGGGGCCTGCCTGATGGGTCCCGCACT-GTCACCTGGAAGCAGAG-3	NULL
'	NULL
Nuclear	NULL
Run-on	NULL
Analysis-Nuclear	NULL
run-on	NULL
analyses	NULL
were	NULL
done	NULL
according	NULL
to	NULL
Greenberg	NULL
and	NULL
Ziff	NULL
(	NULL
9	NULL
)	NULL
.	NULL

In	NULL
brief	NULL
,	NULL
cells	NULL
were	NULL
pretreated	NULL
and	NULL
stimulated	NULL
for	NULL
90	NULL
min	NULL
and	NULL
then	NULL
lysed	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
1	NULL
%	NULL
Triton-X	NULL
using	NULL
a	NULL
glass	NULL
Dounce	NULL
homogenizer	NULL
.	NULL

Nuclei	NULL
were	NULL
purified	NULL
over	NULL
a	NULL
sucrose	NULL
cushion	NULL
,	NULL
followed	NULL
by	NULL
incubation	NULL
for	NULL
30	NULL
min	NULL
at	NULL
30	NULL
°C	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
'	NULL
The	NULL
abbreviations	NULL
used	NULL
are	NULL
:	NULL
LPS	NULL
,	NULL
lipopolysaccharide	NULL
;	NULL
TNF	NULL
,	NULL
tumor	NULL
necrosis	NULL
factor	NULL
;	NULL
NF-kB	NULL
,	NULL
nuclear	NULL
factor	NULL
«	NULL
B	NULL
;	NULL
HIV	NULL
,	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
;	NULL
LTR	NULL
,	NULL
long	NULL
terminal	NULL
repeat	NULL
.	NULL

17001	NULL
17002	NULL
100	NULL
a	NULL
G	NULL
As	NULL
&	NULL
£	NULL
§	NULL
2	NULL
so	NULL
t	NULL
3	NULL
LPS	NULL
PRE	NULL
,	NULL
-	NULL
#	NULL
+	NULL
A	NULL
LPS	NULL
STIM	NULL
.	NULL

«	NULL
+	NULL
=	NULL
+	NULL
Tolerance	NULL
to	NULL
LPS	NULL
Involves	NULL
Mobilization	NULL
of	NULL
NF-kB	NULL
LPS	NULL
Pre	NULL
.	NULL

-	NULL
~	NULL
*-	NULL
+	NULL
LPS	NULL
STIM	NULL
,	NULL
.	NULL

-	NULL
d	NULL
S	NULL
C	NULL
LPS	NULL
PRE	NULL
.	NULL

=	NULL
®	NULL
*	NULL
LPS	NULL
STIM	NULL
,	NULL
+	NULL
+	NULL
TNF	NULL
sawn	NULL
Fic	NULL
.	NULL

1	NULL
.	NULL

Tolerance	NULL
to	NULL
LPS	NULL
in	NULL
Mono	NULL
Mac	NULL
6	NULL
cells	NULL
.	NULL

Mono	NULL
Mac	NULL
6	NULL
cells	NULL
were	NULL
cultured	NULL
for	NULL
2	NULL
days	NULL
with	NULL
and	NULL
without	NULL
LPS	NULL
(	NULL
20	NULL
ng/ml	NULL
)	NULL
,	NULL
washed	NULL
,	NULL
and	NULL
restimulated	NULL
with	NULL
LPS	NULL
at	NULL
1	NULL
ng/ml	NULL
.	NULL

A	NULL
,	NULL
TNF	NULL
protein	NULL
was	NULL
assayed	NULL
in	NULL
4-h	NULL
supernatants	NULL
using	NULL
the	NULL
WEHI	NULL
164/actinomycin	NULL
D	NULL
bioassay	NULL
using	NULL
3-	NULL
(	NULL
4,5-dimethylthiazol-2-yl	NULL
)	NULL
-2,5-diphenyltetrazolium	NULL
bromide	NULL
as	NULL
indicator	NULL
of	NULL
viable	NULL
cells	NULL
.	NULL

B	NULL
,	NULL
for	NULL
Northern	NULL
blot	NULL
analysis	NULL
,	NULL
mRNA	NULL
was	NULL
prepared	NULL
from	NULL
cells	NULL
stimulated	NULL
for	NULL
2	NULL
h	NULL
,	NULL
followed	NULL
by	NULL
hybridization	NULL
with	NULL
a	NULL
TNF-specific	NULL
oligonucleotide	NULL
(	NULL
one	NULL
of	NULL
six	NULL
experiments	NULL
)	NULL
.	NULL

C	NULL
,	NULL
for	NULL
nuclear	NULL
run-on	NULL
analysis	NULL
,	NULL
cells	NULL
were	NULL
stimulated	NULL
,	NULL
and	NULL
nuclei	NULL
were	NULL
isolated	NULL
and	NULL
incubated	NULL
with	NULL
[	NULL
°*P	NULL
]	NULL
UTP	NULL
for	NULL
90	NULL
min	NULL
.	NULL

Isolated	NULL
RNA	NULL
was	NULL
then	NULL
applied	NULL
to	NULL
filters	NULL
that	NULL
had	NULL
been	NULL
blotted	NULL
with	NULL
a	NULL
TNF	NULL
probe	NULL
or	NULL
a	NULL
control	NULL
probe	NULL
.	NULL

LPS	NULL
PRE	NULL
.	NULL

,	NULL
precultured	NULL
with	NULL
LPS	NULL
;	NULL
LPS	NULL
STIM	NULL
.	NULL

,	NULL
stimulated	NULL
with	NULL
LPS	NULL
.	NULL

[	NULL
*°PJUTP	NULL
.	NULL

RNA	NULL
was	NULL
isolated	NULL
,	NULL
and	NULL
150,000	NULL
cpm	NULL
each	NULL
was	NULL
applied	NULL
to	NULL
nitrocellulose	NULL
membranes	NULL
that	NULL
had	NULL
been	NULL
blotted	NULL
with	NULL
a	NULL
0.6-kilobase	NULL
HindIII/Xhol	NULL
fragment	NULL
from	NULL
exon	NULL
4	NULL
of	NULL
the	NULL
TNF	NULL
gene	NULL
(	NULL
10	NULL
)	NULL
in	NULL
pUC18	NULL
or	NULL
with	NULL
pUC18	NULL
alone	NULL
.	NULL

Hybridization	NULL
was	NULL
carried	NULL
out	NULL
at	NULL
65	NULL
°C	NULL
for	NULL
24	NULL
h.	NULL
Gel	NULL
Shift	NULL
Analysis-Nuclear	NULL
extracts	NULL
were	NULL
isolated	NULL
according	NULL
to	NULL
Dig-nam	NULL
et	NULL
al	NULL
.	NULL

(	NULL
11	NULL
)	NULL
and	NULL
were	NULL
admixed	NULL
with	NULL
a	NULL
P-labeled	NULL
double-stranded	NULL
oligonucleotide	NULL
representing	NULL
the	NULL
-605	NULL
NF-kB	NULL
site	NULL
of	NULL
the	NULL
human	NULL
TNF	NULL
promoter	NULL
(	NULL
12	NULL
)	NULL
.	NULL

Samples	NULL
were	NULL
then	NULL
electrophoresed	NULL
on	NULL
nondenaturing	NULL
polyacrylamide	NULL
gels	NULL
either	NULL
in	NULL
EMSA	NULL
buffer	NULL
(	NULL
6.8	NULL
mm	NULL
Tris-HCl	NULL
,	NULL
3.4	NULL
mn	NULL
sodium	NULL
acetate	NULL
,	NULL
1	NULL
mm	NULL
EDTA	NULL
,	NULL
pH	NULL
8	NULL
)	NULL
or	NULL
in	NULL
0.25	NULL
TBE	NULL
buffer	NULL
(	NULL
22.5	NULL
my	NULL
Tris	NULL
borate	NULL
,	NULL
0.5	NULL
mm	NULL
EDTA	NULL
,	NULL
pH	NULL
8.5	NULL
)	NULL
.	NULL

Reporter	NULL
Gene	NULL
Analysis-Cells	NULL
were	NULL
transfected	NULL
with	NULL
luciferase	NULL
reporter	NULL
constructs	NULL
(	NULL
10	NULL
ug	NULL
of	NULL
DNA/10	NULL
``	NULL
cells	NULL
)	NULL
according	NULL
to	NULL
Shakhov	NULL
et	NULL
al	NULL
.	NULL

(	NULL
13	NULL
)	NULL
using	NULL
DEAE-dextran	NULL
(	NULL
250	NULL
ug/ml	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
then	NULL
cultured	NULL
for	NULL
2	NULL
days	NULL
with	NULL
or	NULL
without	NULL
LPS	NULL
(	NULL
20-50	NULL
ng/m1	NULL
)	NULL
,	NULL
followed	NULL
by	NULL
LPS	NULL
stimulation	NULL
(	NULL
1	NULL
ug/ml	NULL
)	NULL
for	NULL
5-6	NULL
h.	NULL
Luciferase	NULL
activity	NULL
in	NULL
cell	NULL
lysates	NULL
was	NULL
determined	NULL
using	NULL
a	NULL
Model	NULL
LB9501	NULL
luminometer	NULL
(	NULL
Berthold	NULL
,	NULL
Wildbad	NULL
,	NULL
Germany	NULL
)	NULL
.	NULL

Constructs	NULL
employed	NULL
contained	NULL
the	NULL
human	NULL
TNF	NULL
5'-region	NULL
PstW/Hgal	NULL
fragment	NULL
(	NULL
kindly	NULL
provided	NULL
by	NULL
Dr.	NULL
E.	NULL
H.	NULL
Weiss	NULL
)	NULL
(	NULL
14	NULL
)	NULL
,	NULL
which	NULL
was	NULL
cloned	NULL
into	NULL
the	NULL
pxP2	NULL
luciferase	NULL
plasmid	NULL
(	NULL
kindly	NULL
provided	NULL
by	NULL
S.	NULL
Nordeen	NULL
)	NULL
(	NULL
15	NULL
)	NULL
or	NULL
the	NULL
HIV	NULL
LTR	NULL
from	NULL
HxB2	NULL
or	NULL
its	NULL
mutated	NULL
version	NULL
,	NULL
which	NULL
inactivates	NULL
both	NULL
NF-	NULL
«	NULL
B	NULL
sites	NULL
(	NULL
kindly	NULL
provided	NULL
by	NULL
Nicole	NULL
Israel	NULL
)	NULL
(	NULL
16	NULL
)	NULL
.	NULL

RESULTS	NULL
AND	NULL
DISCUSSION	NULL
Tolerance	NULL
to	NULL
LPS	NULL
:	NULL
Effect	NULL
on	NULL
TNF	NULL
and	NULL
CD14-Cells	NULL
of	NULL
the	NULL
human	NULL
monocytic	NULL
cell	NULL
line	NULL
Mono	NULL
Mac	NULL
6	NULL
produce	NULL
high	NULL
levels	NULL
of	NULL
TNF	NULL
when	NULL
stimulated	NULL
with	NULL
LPS	NULL
(	NULL
Fig	NULL
.	NULL

14	NULL
,	NULL
second	NULL
column	NULL
)	NULL
.	NULL

However	NULL
,	NULL
when	NULL
cells	NULL
are	NULL
pretreated	NULL
for	NULL
2	NULL
days	NULL
with	NULL
low	NULL
doses	NULL
of	NULL
LPS	NULL
,	NULL
the	NULL
response	NULL
to	NULL
subsequent	NULL
LPS	NULL
stimulation	NULL
is	NULL
strongly	NULL
reduced	NULL
(	NULL
Fig	NULL
.	NULL

14	NULL
,	NULL
fourth	NULL
column	NULL
)	NULL
.	NULL

Northern	NULL
blot	NULL
analysis	NULL
reveals	NULL
that	NULL
induction	NULL
of	NULL
TNF	NULL
mRNA	NULL
is	NULL
only	NULL
minimal	NULL
in	NULL
LPS-pre-treated	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
,	NULL
which	NULL
is	NULL
due	NULL
to	NULL
reduced	NULL
transcription	NULL
of	NULL
TNF	NULL
mRNA	NULL
as	NULL
shown	NULL
by	NULL
nuclear	NULL
run-on	NULL
analysis	NULL
(	NULL
Fig	NULL
.	NULL

1C	NULL
)	NULL
.	NULL

Tolerance	NULL
to	NULL
LPS	NULL
is	NULL
not	NULL
restricted	NULL
to	NULL
TNF	NULL
,	NULL
but	NULL
,	NULL
as	NULL
reported	NULL
previously	NULL
,	NULL
expression	NULL
of	NULL
the	NULL
cytokines	NULL
interleukin-1	NULL
and	NULL
-6	NULL
is	NULL
also	NULL
down-regulated	NULL
upon	NULL
repeated	NULL
LPS	NULL
stimulation	NULL
(	NULL
17	NULL
)	NULL
.	NULL

The	NULL
classical	NULL
mechanism	NULL
of	NULL
tolerance	NULL
would	NULL
call	NULL
for	NULL
the	NULL
disappearance	NULL
of	NULL
LPS	NULL
receptors	NULL
from	NULL
the	NULL
cell	NULL
surface	NULL
.	NULL

While	NULL
several	NULL
LPS-binding	NULL
proteins	NULL
have	NULL
been	NULL
described	NULL
to	NULL
occur	NULL
on	NULL
monocytes	NULL
,	NULL
an	NULL
involvement	NULL
in	NULL
LPS	NULL
signaling	NULL
has	NULL
been	NULL
demonstrated	NULL
only	NULL
for	NULL
CD14	NULL
(	NULL
18	NULL
,	NULL
19	NULL
)	NULL
.	NULL

The	NULL
CD14	NULL
molecule	NULL
is	NULL
also	NULL
expressed	NULL
on	NULL
Mono	NULL
Mac	NULL
6	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
,	NULL
upper	NULL
panel	NULL
)	NULL
.	NULL

Tolerance	NULL
induction	NULL
by	NULL
LPS	NULL
does	NULL
not	NULL
decrease	NULL
CD14	NULL
expression	NULL
,	NULL
but	NULL
leads	NULL
to	NULL
a	NULL
substantial	NULL
increase	NULL
in	NULL
CD14-specific	NULL
immunofluorescence	NULL
staining	NULL
(	NULL
Fig	NULL
.	NULL

A	NULL
B	NULL
Ik	NULL
64	NULL
ch	NULL
CD	NULL
14	NULL
(	NULL
My-4	NULL
)	NULL
Fic	NULL
.	NULL

2	NULL
.	NULL

Effect	NULL
of	NULL
tolerance	NULL
induction	NULL
on	NULL
expression	NULL
of	NULL
CD14	NULL
.	NULL

Mono	NULL
Mac	NULL
6	NULL
cells	NULL
were	NULL
treated	NULL
for	NULL
2	NULL
days	NULL
with	NULL
LPS	NULL
(	NULL
20	NULL
ng/ml	NULL
)	NULL
.	NULL

A	NULL
,	NULL
cells	NULL
were	NULL
then	NULL
analyzed	NULL
for	NULL
CD14	NULL
cell-surface	NULL
expression	NULL
by	NULL
staining	NULL
with	NULL
antibody	NULL
My4	NULL
(	NULL
right-hand	NULL
curve	NULL
)	NULL
or	NULL
with	NULL
isotype	NULL
control	NULL
.	NULL

10,000	NULL
cells	NULL
were	NULL
then	NULL
recorded	NULL
by	NULL
flow	NULL
cytometry	NULL
.	NULL

Staining	NULL
is	NULL
given	NULL
as	NULL
mean	NULL
specific	NULL
fluorescence	NULL
intensity	NULL
in	NULL
channels	NULL
(	NULL
CH	NULL
)	NULL
(	NULL
one	NULL
of	NULL
six	NULL
experiments	NULL
)	NULL
.	NULL

B	NULL
,	NULL
for	NULL
Northern	NULL
blot	NULL
analysis	NULL
,	NULL
RNA	NULL
was	NULL
isolated	NULL
from	NULL
cells	NULL
cultured	NULL
for	NULL
2	NULL
days	NULL
with	NULL
and	NULL
without	NULL
LPS	NULL
at	NULL
20	NULL
ng/ml	NULL
.	NULL

Blots	NULL
were	NULL
probed	NULL
with	NULL
a	NULL
P-labeled	NULL
oligonucleotide	NULL
specific	NULL
for	NULL
CD14	NULL
(	NULL
one	NULL
of	NULL
four	NULL
experiments	NULL
)	NULL
(	NULL
35	NULL
)	NULL
.	NULL

2A	NULL
,	NULL
lower	NULL
panel	NULL
)	NULL
.	NULL

This	NULL
effect	NULL
is	NULL
not	NULL
due	NULL
to	NULL
transport	NULL
of	NULL
pre-formed	NULL
protein	NULL
to	NULL
the	NULL
cell	NULL
surface	NULL
,	NULL
but	NULL
appears	NULL
to	NULL
result	NULL
from	NULL
an	NULL
increased	NULL
biosynthesis	NULL
since	NULL
CD14	NULL
transcripts	NULL
show	NULL
a	NULL
substantial	NULL
increase	NULL
in	NULL
tolerant	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
tolerance	NULL
to	NULL
LPS	NULL
does	NULL
not	NULL
result	NULL
from	NULL
a	NULL
disappearance	NULL
of	NULL
the	NULL
LPS	NULL
receptor	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
affinity	NULL
of	NULL
the	NULL
LPS-CD14	NULL
interaction	NULL
is	NULL
only	NULL
slightly	NULL
reduced	NULL
in	NULL
tolerant	NULL
Mono	NULL
Mac	NULL
6	NULL
cells	NULL
(	NULL
20	NULL
)	NULL
.	NULL

The	NULL
CD14	NULL
receptor	NULL
may	NULL
,	NULL
however	NULL
,	NULL
be	NULL
uncoupled	NULL
from	NULL
the	NULL
downstream	NULL
signal	NULL
transduction	NULL
pathways	NULL
.	NULL

One	NULL
essential	NULL
component	NULL
of	NULL
the	NULL
cytoplasmic/nuclear	NULL
transduction	NULL
pathway	NULL
in	NULL
the	NULL
LPS	NULL
response	NULL
is	NULL
the	NULL
inducible	NULL
transcription	NULL
factor	NULL
NF-kB	NULL
(	NULL
21	NULL
)	NULL
,	NULL
a	NULL
nuclear	NULL
factor	NULL
involved	NULL
in	NULL
transcriptional	NULL
control	NULL
of	NULL
cytokine	NULL
genes	NULL
including	NULL
TNF	NULL
(	NULL
12	NULL
,	NULL
13	NULL
)	NULL
.	NULL

NF-kB	NULL
Protein	NULL
and	NULL
RNA-In	NULL
human	NULL
monocytes	NULL
,	NULL
nuclear	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
activity	NULL
is	NULL
present	NULL
constitutively	NULL
(	NULL
Fig	NULL
.	NULL

34	NULL
)	NULL
,	NULL
and	NULL
LPS	NULL
stimulation	NULL
strongly	NULL
increases	NULL
DNA	NULL
binding	NULL
activity	NULL
in	NULL
nuclear	NULL
extracts	NULL
.	NULL

Similarly	NULL
,	NULL
cells	NULL
rendered	NULL
tolerant	NULL
to	NULL
LPS	NULL
show	NULL
Tolerance	NULL
to	NULL
LPS	NULL
Involves	NULL
Mobilization	NULL
of	NULL
NF-kB	NULL
A	NULL
B	NULL
LPS	NULL
PRE	NULL
,	NULL
mols	NULL
+0	NULL
+	NULL
LPS	NULL
PRE	NULL
,	NULL
=	NULL
LPS	NULL
STIM	NULL
,	NULL
-	NULL
+	NULL
~	NULL
+	NULL
LPS	NULL
STIM	NULL
.	NULL

-	NULL
+	NULL
w	NULL
o	NULL
bo	NULL
ug	NULL
v	NULL
»	NULL
bath	NULL
|	NULL
bead	NULL
si	NULL
bit	NULL
tag	NULL
band	NULL
Gn	NULL
}	NULL
-	NULL
..	NULL
17003	NULL
C	NULL
LPS	NULL
Pre	NULL
.	NULL

-	NULL
-	NULL
+	NULL
+	NULL
LPS	NULL
Stim	NULL
.	NULL

-	NULL
+	NULL
-	NULL
+	NULL
P105	NULL
--	NULL
#	NULL
2	NULL
e	NULL
®	NULL
hes	NULL
e	NULL
0	NULL
a	NULL
&	NULL
Fic	NULL
.	NULL

3	NULL
.	NULL

Mobilization	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
NF-kB	NULL
mRNA	NULL
in	NULL
tolerant	NULL
Mono	NULL
Mac	NULL
6	NULL
cells	NULL
.	NULL

Cells	NULL
were	NULL
pretreated	NULL
with	NULL
and	NULL
without	NULL
LPS	NULL
(	NULL
LPS	NULL
PRE	NULL
.	NULL
)	NULL

at	NULL
50	NULL
ng/ml	NULL
for	NULL
2	NULL
days	NULL
,	NULL
followed	NULL
by	NULL
stimulation	NULL
for	NULL
1	NULL
h	NULL
with	NULL
LPS	NULL
(	NULL
LPS	NULL
STIM	NULL
.	NULL
)	NULL

at	NULL
1	NULL
ug/ml	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
admixed	NULL
with	NULL
a	NULL
P-labeled	NULL
oligonucleotide	NULL
representing	NULL
the	NULL
-605	NULL
NF-kB	NULL
motif	NULL
of	NULL
the	NULL
human	NULL
TNF	NULL
promoter	NULL
.	NULL

A	NULL
,	NULL
electrophoresis	NULL
was	NULL
carried	NULL
out	NULL
in	NULL
EMSA	NULL
buffer	NULL
.	NULL

The	NULL
arrou	NULL
denotes	NULL
the	NULL
specific	NULL
NF-	NULL
«	NULL
B	NULL
band	NULL
(	NULL
one	NULL
of	NULL
six	NULL
experiments	NULL
)	NULL
.	NULL

B	NULL
,	NULL
electrophoresis	NULL
was	NULL
carried	NULL
out	NULL
in	NULL
0.25	NULL
m	NULL
TBE	NULL
buffer	NULL
.	NULL

/	NULL
and	NULL
II	NULL
are	NULL
specific	NULL
binding	NULL
proteins	NULL
,	NULL
and	NULL
Z7	NULL
is	NULL
nonspecific	NULL
(	NULL
one	NULL
of	NULL
six	NULL
experiments	NULL
)	NULL
.	NULL

C	NULL
,	NULL
mRNA	NULL
was	NULL
isolated	NULL
from	NULL
Mono	NULL
Mac	NULL
6	NULL
cells	NULL
cultured	NULL
for	NULL
2	NULL
days	NULL
with	NULL
and	NULL
without	NULL
LPS	NULL
(	NULL
20	NULL
ng/m	NULL
!	NULL

1	NULL
)	NULL
,	NULL
followed	NULL
by	NULL
stimulation	NULL
with	NULL
and	NULL
without	NULL
LPS	NULL
at	NULL
1	NULL
ug/ml	NULL
.	NULL

10	NULL
ug	NULL
of	NULL
RNAM/lane	NULL
was	NULL
hybridized	NULL
with	NULL
an	NULL
oligonucleotide	NULL
specific	NULL
for	NULL
p105	NULL
or	NULL
p65	NULL
(	NULL
one	NULL
of	NULL
four	NULL
experiments	NULL
)	NULL
.	NULL

constitutive	NULL
NF-KB	NULL
activity	NULL
,	NULL
and	NULL
LPS	NULL
stimulation	NULL
also	NULL
results	NULL
in	NULL
rapid	NULL
mobilization	NULL
of	NULL
NF-kB	NULL
binding	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
)	NULL
(	NULL
22	NULL
)	NULL
.	NULL

This	NULL
strongly	NULL
supports	NULL
the	NULL
notion	NULL
that	NULL
the	NULL
LPS	NULL
receptor	NULL
is	NULL
functional	NULL
and	NULL
not	NULL
uncoupled	NULL
from	NULL
nuclear	NULL
events	NULL
.	NULL

When	NULL
LPS-tolerant	NULL
cells	NULL
are	NULL
challenged	NULL
with	NULL
other	NULL
stimuli	NULL
like	NULL
phorbol	NULL
esters	NULL
,	NULL
there	NULL
is	NULL
a	NULL
similar	NULL
mobilization	NULL
of	NULL
NF-kB	NULL
,	NULL
but	NULL
no	NULL
TNF	NULL
transcription	NULL
(	NULL
22	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
LPS	NULL
tolerance	NULL
is	NULL
heterolo-gous	NULL
and	NULL
extends	NULL
to	NULL
other	NULL
signals	NULL
.	NULL

To	NULL
achieve	NULL
a	NULL
better	NULL
resolution	NULL
of	NULL
protein-DNA	NULL
complexes	NULL
,	NULL
we	NULL
used	NULL
0.25	NULL
x	NULL
TBE	NULL
buffer	NULL
for	NULL
native	NULL
gel	NULL
electrophoresis	NULL
.	NULL

This	NULL
allowed	NULL
for	NULL
the	NULL
separation	NULL
of	NULL
two	NULL
complexes	NULL
,	NULL
referred	NULL
to	NULL
as	NULL
complexes	NULL
I	NULL
and	NULL
II	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

Complex	NULL
II	NULL
co-migrates	NULL
with	NULL
the	NULL
constitutive	NULL
complex	NULL
from	NULL
K-562	NULL
cells	NULL
overexpressing	NULL
transfected	NULL
NF-	NULL
«	NULL
B	NULL
p50	NULL
subunit	NULL
;	NULL
and	NULL
an	NULL
antiserum	NULL
to	NULL
p50	NULL
will	NULL
super-shift	NULL
complexes	NULL
I	NULL
and	NULL
II	NULL
,	NULL
while	NULL
an	NULL
antiserum	NULL
to	NULL
p65	NULL
shifts	NULL
only	NULL
complex	NULL
I	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
(	NULL
12	NULL
)	NULL
.	NULL

This	NULL
confirms	NULL
the	NULL
previous	NULL
conclusion	NULL
(	NULL
23-25	NULL
)	NULL
that	NULL
complex	NULL
I	NULL
represents	NULL
the	NULL
p50-p65	NULL
het-erodimer	NULL
(	NULL
products	NULL
of	NULL
NF-	NULL
«	NULL
B-1	NULL
and	NULL
the	NULL
re/A	NULL
gene	NULL
,	NULL
respectively	NULL
)	NULL
and	NULL
that	NULL
complex	NULL
II	NULL
represents	NULL
a	NULL
homodimer	NULL
of	NULL
the	NULL
p50	NULL
subunit	NULL
.	NULL

In	NULL
these	NULL
analyses	NULL
,	NULL
we	NULL
did	NULL
not	NULL
detect	NULL
additional	NULL
bands	NULL
suggestive	NULL
of	NULL
p65	NULL
homodimers	NULL
.	NULL

In	NULL
LPS-stimulated	NULL
Mono	NULL
Mac	NULL
6	NULL
cells	NULL
,	NULL
the	NULL
p50-p65	NULL
complex	NULL
is	NULL
dominant	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
LPS-tolerant	NULL
cells	NULL
stimulated	NULL
with	NULL
LPS	NULL
show	NULL
a	NULL
predominance	NULL
of	NULL
the	NULL
p50	NULL
homodimer	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

Densitometric	NULL
analysis	NULL
gives	NULL
an	NULL
average	NULL
ratio	NULL
of	NULL
p50-p65	NULL
to	NULL
p50	NULL
homodimer	NULL
of	NULL
1.4	NULL
+	NULL
0.2	NULL
,	NULL
while	NULL
in	NULL
tolerant	NULL
cells	NULL
,	NULL
this	NULL
ratio	NULL
is	NULL
lowered	NULL
to	NULL
0.8	NULL
+	NULL
0.1	NULL
(	NULL
n	NULL
=	NULL
6	NULL
)	NULL
.	NULL

Mobilization	NULL
of	NULL
NF-kB	NULL
in	NULL
both	NULL
naive	NULL
and	NULL
LPS-tolerant	NULL
cells	NULL
can	NULL
be	NULL
blocked	NULL
by	NULL
treatment	NULL
with	NULL
the	NULL
My4	NULL
antibody	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
CD14	NULL
is	NULL
the	NULL
essential	NULL
receptor	NULL
in	NULL
this	NULL
system	NULL
.	NULL

The	NULL
increase	NULL
in	NULL
p50	NULL
homodimer	NULL
DNA	NULL
binding	NULL
activity	NULL
may	NULL
be	NULL
due	NULL
to	NULL
new	NULL
synthesis	NULL
of	NULL
p50	NULL
protein	NULL
from	NULL
its	NULL
precursor	NULL
,	NULL
p105	NULL
.	NULL

We	NULL
observed	NULL
that	NULL
p105	NULL
mRNA	NULL
levels	NULL
are	NULL
up-regulated	NULL
upon	NULL
stimulation	NULL
of	NULL
Mono	NULL
Mac	NULL
6	NULL
cells	NULL
with	NULL
LPS	NULL
,	NULL
while	NULL
p65	NULL
mRNA	NULL
levels	NULL
are	NULL
unaffected	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

Tolerant	NULL
cells	NULL
show	NULL
an	NULL
increased	NULL
level	NULL
of	NULL
p105	NULL
mRNA	NULL
,	NULL
which	NULL
is	NULL
further	NULL
augmented	NULL
upon	NULL
secondary	NULL
LPS	NULL
treatment	NULL
.	NULL

This	NULL
may	NULL
allow	NULL
for	NULL
increased	NULL
translation	NULL
of	NULL
p105	NULL
and	NULL
its	NULL
increased	NULL
processing	NULL
to	NULL
p50	NULL
protein	NULL
.	NULL

The	NULL
p50	NULL
homodimer	NULL
is	NULL
known	NULL
to	NULL
translocate	NULL
independently	NULL
to	NULL
the	NULL
nucleus	NULL
,	NULL
to	NULL
escape	NULL
inhibition	NULL
of	NULL
IKb-	NULL
«	NULL
,	NULL
and	NULL
to	NULL
down-regulate	NULL
transcription	NULL
from	NULL
NF-	NULL
«	NULL
B	NULL
sites	NULL
(	NULL
25	NULL
,	NULL
26	NULL
)	NULL
.	NULL

Reporter	NULL
Gene	NULL
Analysis-To	NULL
test	NULL
whether	NULL
the	NULL
altered	NULL
NF-	NULL
«	NULL
B	NULL
composition	NULL
affects	NULL
gene	NULL
expression	NULL
,	NULL
we	NULL
transfected	NULL
NF-	NULL
«	NULL
B-dependent	NULL
HIV-1	NULL
LTR	NULL
reporter	NULL
gene	NULL
constructs	NULL
,	NULL
followed	NULL
by	NULL
preculture	NULL
with	NULL
or	NULL
without	NULL
LPS	NULL
and	NULL
by	NULL
measurement	NULL
of	NULL
luciferase	NULL
activity	NULL
.	NULL

LPS	NULL
stimulation	NULL
of	NULL
Mono	NULL
Mac	NULL
6	NULL
cells	NULL
induces	NULL
a	NULL
6-fold	NULL
enhancement	NULL
of	NULL
LTR	NULL
activity	NULL
,	NULL
while	NULL
a	NULL
construct	NULL
with	NULL
mutations	NULL
in	NULL
both	NULL
NF-	NULL
«	NULL
B	NULL
sites	NULL
shows	NULL
no	NULL
or	NULL
only	NULL
minimally	NULL
increased	NULL
reporter	NULL
gene	NULL
expression	NULL
(	NULL
1.5-fold	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
)	NULL
.	NULL

When	NULL
LPS-tolerant	NULL
Mono	NULL
Mac	NULL
6	NULL
cells	NULL
are	NULL
tested	NULL
,	NULL
LPS	NULL
stimulation	NULL
does	NULL
not	NULL
increase	NULL
transactivation	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B-dependent	NULL
HIV-1	NULL
LTR	NULL
reporter	NULL
gene	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
.	NULL

This	NULL
indicates	NULL
that	NULL
the	NULL
composition	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
complexes	NULL
mobilized	NULL
in	NULL
LPS-tolerant	NULL
cells	NULL
is	NULL
functionally	NULL
inac-tive	NULL
.	NULL

This	NULL
also	NULL
applies	NULL
to	NULL
transcription	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B-dependent	NULL
TNF	NULL
gene	NULL
.	NULL

Using	NULL
a	NULL
TNF	NULL
promoter-controlled	NULL
luciferase	NULL
reporter	NULL
construct	NULL
,	NULL
we	NULL
observed	NULL
that	NULL
LPS-responsive	NULL
Mono	NULL
Mac	NULL
6	NULL
cells	NULL
induce	NULL
a	NULL
strong	NULL
transactivation	NULL
,	NULL
while	NULL
LPS-tolerant	NULL
cells	NULL
show	NULL
only	NULL
a	NULL
minimal	NULL
response	NULL
(	NULL
Fig	NULL
.	NULL

4C	NULL
)	NULL
.	NULL

Hence	NULL
,	NULL
it	NULL
appears	NULL
that	NULL
p50	NULL
induced	NULL
by	NULL
LPS	NULL
tolerance	NULL
lacks	NULL
transactivation	NULL
activity	NULL
and	NULL
instead	NULL
occupies	NULL
the	NULL
cognate	NULL
NF-	NULL
«	NULL
B-binding	NULL
site	NULL
and	NULL
prevents	NULL
transactivation	NULL
by	NULL
the	NULL
p50-p65	NULL
complex	NULL
.	NULL

This	NULL
notion	NULL
is	NULL
supported	NULL
by	NULL
transfection	NULL
studies	NULL
with	NULL
Mono	NULL
Mac	NULL
6	NULL
cells	NULL
in	NULL
which	NULL
cotransfection	NULL
of	NULL
the	NULL
p50	NULL
expression	NULL
plasmid	NULL
with	NULL
the	NULL
TNF	NULL
promoter	NULL
gene	NULL
construct	NULL
led	NULL
to	NULL
reduced	NULL
constitutive	NULL
and	NULL
LPS-in-duced	NULL
reporter	NULL
gene	NULL
activity	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

A	NULL
similar	NULL
negative	NULL
effect	NULL
of	NULL
p50	NULL
has	NULL
been	NULL
reported	NULL
previously	NULL
for	NULL
the	NULL
interleukin-2	NULL
promoter	NULL
and	NULL
the	NULL
HIV	NULL
LTR	NULL
in	NULL
that	NULL
overexpression	NULL
of	NULL
p50	NULL
results	NULL
in	NULL
repression	NULL
of	NULL
responses	NULL
(	NULL
25	NULL
,	NULL
27	NULL
)	NULL
.	NULL

Tolerance	NULL
in	NULL
Primary	NULL
Monocytes-When	NULL
looking	NULL
at	NULL
primary	NULL
human	NULL
blood	NULL
monocytes	NULL
precultured	NULL
with	NULL
LPS	NULL
,	NULL
we	NULL
also	NULL
observed	NULL
a	NULL
down-regulation	NULL
of	NULL
TNF	NULL
production	NULL
and	NULL
an	NULL
up-regulation	NULL
of	NULL
or	NULL
no	NULL
change	NULL
in	NULL
cell-surface	NULL
CD14	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
LPS	NULL
stimulation	NULL
of	NULL
naive	NULL
cells	NULL
gives	NULL
a	NULL
predominance	NULL
of	NULL
p50-p65	NULL
over	NULL
p50	NULL
homodimers	NULL
(	NULL
ratio	NULL
of	NULL
1.8	NULL
+	NULL
0.6	NULL
)	NULL
,	NULL
while	NULL
stimulation	NULL
of	NULL
LPS-tolerant	NULL
blood	NULL
monocytes	NULL
is	NULL
associated	NULL
with	NULL
a	NULL
relative	NULL
increase	NULL
in	NULL
the	NULL
p50	NULL
homodimer	NULL
(	NULL
ratio	NULL
of	NULL
0.8	NULL
+	NULL
0.1	NULL
,	NULL
n	NULL
=	NULL
3	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
mechanisms	NULL
similar	NULL
to	NULL
those	NULL
described	NULL
herein	NULL
for	NULL
Mono	NULL
Mac	NULL
6	NULL
may	NULL
also	NULL
operate	NULL
in	NULL
primary	NULL
blood	NULL
monocytes	NULL
.	NULL

Concluding	NULL
Remarks-Earlier	NULL
studies	NULL
have	NULL
shown	NULL
that	NULL
NF-	NULL
«	NULL
B	NULL
itself	NULL
may	NULL
participate	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
p105	NULL
expression	NULL
through	NULL
NF-	NULL
«	NULL
B	NULL
motifs	NULL
in	NULL
the	NULL
p105	NULL
promoter	NULL
(	NULL
28	NULL
,	NULL
29	NULL
)	NULL
,	NULL
while	NULL
17004	NULL
LPS	NULL
pre	NULL
.	NULL

n	NULL
*~	NULL
-	NULL
+	NULL
-	NULL
+	NULL
A	NULL
B	NULL
C	NULL
Fold	NULL
transactivation	NULL
by	NULL
LPS	NULL
stimulation	NULL
w	NULL
|	NULL
m	NULL
G	NULL
A	NULL
a	NULL
0	NULL
,	NULL
c	NULL
HIVALTR	NULL
HIV-LIR	NULL
AKB	NULL
HIVLTR	NULL
Hu	NULL
TNF6	NULL
``	NULL
Region	NULL
Fic	NULL
.	NULL

4	NULL
.	NULL

Functional	NULL
activity	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
untreated	NULL
and	NULL
tolerant	NULL
Mono	NULL
Mac	NULL
6	NULL
cells	NULL
,	NULL
A-C	NULL
,	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
luciferase	NULL
reporter	NULL
plasmids	NULL
,	NULL
followed	NULL
by	NULL
2-day	NULL
culture	NULL
with	NULL
and	NULL
without	NULL
LPS	NULL
(	NULL
20	NULL
ng/ml	NULL
)	NULL
and	NULL
stimulation	NULL
by	NULL
LPS	NULL
(	NULL
1	NULL
ug/ml	NULL
)	NULL
for	NULL
5-6	NULL
h	NULL
before	NULL
assay	NULL
of	NULL
luciferase	NULL
activity	NULL
in	NULL
cell	NULL
lysates	NULL
.	NULL

Promoter	NULL
fragments	NULL
were	NULL
the	NULL
HIV	NULL
LTR	NULL
from	NULL
HxB2	NULL
and	NULL
its	NULL
mutated	NULL
version	NULL
,	NULL
which	NULL
inactivates	NULL
both	NULL
NF-	NULL
«	NULL
B	NULL
sites	NULL
or	NULL
the	NULL
PstU/Hgal	NULL
fragment	NULL
(	NULL
1084	NULL
base	NULL
pairs	NULL
)	NULL
of	NULL
the	NULL
human	NULL
(	NULL
Hu	NULL
)	NULL
TNF	NULL
5'-region	NULL
.	NULL

Data	NULL
represent	NULL
fold	NULL
transactivation	NULL
by	NULL
LPS	NULL
stimulation	NULL
in	NULL
cells	NULL
without	NULL
and	NULL
with	NULL
LPS	NULL
preculture	NULL
(	NULL
LPS	NULL
pre	NULL
.	NULL
)	NULL

at	NULL
20	NULL
ng	NULL
of	NULL
LPS/ml	NULL
(	NULL
mean	NULL
+	NULL
S.D	NULL
.	NULL

,	NULL
n	NULL
=	NULL
6	NULL
,	NULL
5	NULL
,	NULL
and	NULL
3	NULL
for	NULL
A-C	NULL
,	NULL
respectively	NULL
.	NULL

the	NULL
p65	NULL
promoter	NULL
does	NULL
not	NULL
contain	NULL
such	NULL
a	NULL
motif	NULL
(	NULL
30	NULL
)	NULL
.	NULL

Since	NULL
tolerant	NULL
cells	NULL
are	NULL
still	NULL
able	NULL
to	NULL
respond	NULL
to	NULL
LPS	NULL
with	NULL
enhanced	NULL
transcription	NULL
of	NULL
p105	NULL
(	NULL
while	NULL
transcription	NULL
of	NULL
TNF	NULL
is	NULL
blocked	NULL
)	NULL
,	NULL
it	NULL
appears	NULL
that	NULL
in	NULL
the	NULL
p105	NULL
promoter	NULL
,	NULL
p50	NULL
may	NULL
have	NULL
transactivation	NULL
activity	NULL
,	NULL
similar	NULL
to	NULL
what	NULL
has	NULL
been	NULL
reported	NULL
for	NULL
major	NULL
his-tocompatibility	NULL
complex	NULL
class	NULL
I	NULL
expression	NULL
(	NULL
31	NULL
,	NULL
32	NULL
)	NULL
.	NULL

This	NULL
transactivation	NULL
by	NULL
p50	NULL
may	NULL
be	NULL
subject	NULL
to	NULL
control	NULL
by	NULL
Bel-3	NULL
(	NULL
33	NULL
,	NULL
34	NULL
)	NULL
.	NULL

Our	NULL
study	NULL
shows	NULL
that	NULL
LPS-tolerant	NULL
cells	NULL
can	NULL
still	NULL
be	NULL
activated	NULL
by	NULL
LPS	NULL
to	NULL
mobilize	NULL
NF-	NULL
«	NULL
B	NULL
DNA-binding	NULL
proteins	NULL
.	NULL

This	NULL
NF-	NULL
«	NULL
B	NULL
complex	NULL
,	NULL
due	NULL
to	NULL
a	NULL
predominance	NULL
of	NULL
p50	NULL
,	NULL
will	NULL
not	NULL
transactivate	NULL
the	NULL
TNF	NULL
promoter	NULL
.	NULL

This	NULL
novel	NULL
mechanism	NULL
of	NULL
down-regulation	NULL
of	NULL
gene	NULL
expression	NULL
in	NULL
monocytes	NULL
may	NULL
apply	NULL
to	NULL
other	NULL
NF-	NULL
«	NULL
B-dependent	NULL
cytokines	NULL
and	NULL
receptors	NULL
and	NULL
to	NULL
viruses	NULL
like	NULL
HIV	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
up-regulation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p50	NULL
could	NULL
offer	NULL
a	NULL
general	NULL
approach	NULL
to	NULL
control	NULL
diseases	NULL
that	NULL
involve	NULL
activation	NULL
of	NULL
monocytes	NULL
and	NULL
macrophages	NULL
.	NULL

Acknowledgments-We	NULL
thank	NULL
Dr.	NULL
E.	NULL
H.	NULL
Weiss	NULL
for	NULL
providing	NULL
the	NULL
TNF	NULL
promoter	NULL
fragment	NULL
and	NULL
Drs	NULL
.	NULL

Nicole	NULL
and	NULL
Alain	NULL
Israel	NULL
for	NULL
the	NULL
HIV	NULL
LTR	NULL
reporter	NULL
plasmids	NULL
and	NULL
the	NULL
p50	NULL
expression	NULL
plasmid	NULL
,	NULL
respectively	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Sibley	NULL
,	NULL
D.	NULL
R.	NULL
,	NULL
and	NULL
Lefkowitz	NULL
,	NULL
R.	NULL
J	NULL
.	NULL

(	NULL
1985	NULL
)	NULL
Nature	NULL
317	NULL
,	NULL
124-129	NULL
2	NULL
.	NULL

Beeson	NULL
,	NULL
P.	NULL
B	NULL
.	NULL

(	NULL
1947	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

86	NULL
,	NULL
29-44	NULL
3	NULL
.	NULL

O'Malley	NULL
,	NULL
W.	NULL
E.	NULL
,	NULL
Achinstein	NULL
,	NULL
B.	NULL
,	NULL
and	NULL
Shear	NULL
,	NULL
M.	NULL
J	NULL
.	NULL

(	NULL
1962	NULL
)	NULL
J.	NULL
Nat	NULL
.	NULL

Cancer	NULL
Inst	NULL
.	NULL

29	NULL
,	NULL
1169-1175	NULL
13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

Tolerance	NULL
to	NULL
LPS	NULL
Involves	NULL
Mobilization	NULL
of	NULL
NF-kB	NULL
4	NULL
.	NULL

Mathison	NULL
,	NULL
J.	NULL
C.	NULL
,	NULL
Virca	NULL
,	NULL
G.	NULL
D.	NULL
,	NULL
Wolfson	NULL
,	NULL
E.	NULL
,	NULL
Tobias	NULL
,	NULL
P.	NULL
S.	NULL
,	NULL
Glaser	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Ulevitch	NULL
,	NULL
R.	NULL
J	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

85	NULL
,	NULL
1108-1118	NULL
.	NULL

Freudenberg	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
and	NULL
Galanos	NULL
,	NULL
C.	NULL
(	NULL
1988	NULL
)	NULL
Infect	NULL
.	NULL

Immun	NULL
.	NULL

56	NULL
,	NULL
1352-1357	NULL
.	NULL

Ziegler-Heitbrock	NULL
,	NULL
H.	NULL
W.	NULL
L.	NULL
,	NULL
Thiel	NULL
,	NULL
E.	NULL
,	NULL
Fiitterer	NULL
,	NULL
A.	NULL
,	NULL
Herzog	NULL
,	NULL
V.	NULL
,	NULL
Wirtz	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Riethmiller	NULL
,	NULL
G.	NULL
(	NULL
1988	NULL
)	NULL
Int	NULL
.	NULL

J	NULL
.	NULL

Cancer	NULL
41	NULL
,	NULL
456-461	NULL
.	NULL

Ziegler-Heitbrock	NULL
,	NULL
H.	NULL
W.	NULL
L.	NULL
,	NULL
Kifferlein	NULL
,	NULL
E.	NULL
,	NULL
Haas	NULL
,	NULL
J.	NULL
G.	NULL
,	NULL
Meyer	NULL
,	NULL
N.	NULL
,	NULL
Strobel	NULL
,	NULL
M.	NULL
,	NULL
Weber	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Flieger	NULL
,	NULL
D.	NULL
(	NULL
1992	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

148	NULL
,	NULL
1753-1758	NULL
.	NULL

Chirgwin	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Przybyla	NULL
,	NULL
A.	NULL
E.	NULL
,	NULL
MacDonald	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
and	NULL
Rutter	NULL
,	NULL
W.	NULL
J	NULL
.	NULL

(	NULL
1979	NULL
)	NULL
Biochemistry	NULL
18	NULL
,	NULL
5294-5299	NULL
.	NULL

Greenberg	NULL
,	NULL
M.	NULL
E.	NULL
,	NULL
and	NULL
Ziff	NULL
,	NULL
E.	NULL
B	NULL
.	NULL

(	NULL
1984	NULL
)	NULL
Nature	NULL
311	NULL
,	NULL
433-438	NULL
.	NULL

Haas	NULL
,	NULL
J.	NULL
G.	NULL
,	NULL
Thiel	NULL
,	NULL
C.	NULL
,	NULL
Blomer	NULL
,	NULL
K.	NULL
,	NULL
Weiss	NULL
,	NULL
E.	NULL
H.	NULL
,	NULL
Riethmiiller	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
Ziegler	NULL
Heitbrock	NULL
,	NULL
H.	NULL
W.	NULL
L.	NULL
(	NULL
1989	NULL
)	NULL
J.	NULL
Leukocyte	NULL
Biol	NULL
.	NULL

46	NULL
,	NULL
11-14	NULL
.	NULL

Dignam	NULL
,	NULL
J.	NULL
P.	NULL
,	NULL
Lebovitz	NULL
,	NULL
R.	NULL
M.	NULL
,	NULL
and	NULL
Roeder	NULL
,	NULL
R.	NULL
G.	NULL
(	NULL
1983	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

11	NULL
,	NULL
1475-1489	NULL
.	NULL

Ziegler-Heitbrock	NULL
,	NULL
H.	NULL
W.	NULL
L.	NULL
,	NULL
Sternsdorf	NULL
,	NULL
T.	NULL
,	NULL
Liese	NULL
,	NULL
J.	NULL
,	NULL
Belohradsky	NULL
,	NULL
B.	NULL
,	NULL
Weber	NULL
,	NULL
C.	NULL
,	NULL
Wedel	NULL
,	NULL
A.	NULL
,	NULL
Schreck	NULL
,	NULL
R.	NULL
,	NULL
B	NULL
&	NULL
uerle	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Strobel	NULL
,	NULL
M.	NULL
(	NULL
1993	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

151	NULL
,	NULL
6986-6993	NULL
Shakhov	NULL
,	NULL
A.	NULL
N.	NULL
,	NULL
Collart	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
Vassalli	NULL
,	NULL
P.	NULL
,	NULL
Nedospasov	NULL
,	NULL
S.	NULL
A.	NULL
,	NULL
and	NULL
Jongeneel	NULL
,	NULL
C.	NULL
V.	NULL
(	NULL
1990	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

171	NULL
,	NULL
35-47	NULL
Messer	NULL
,	NULL
G.	NULL
,	NULL
Spengler	NULL
,	NULL
U.	NULL
,	NULL
Jung	NULL
,	NULL
M.	NULL
C.	NULL
,	NULL
Honold	NULL
,	NULL
G.	NULL
,	NULL
Blomer	NULL
,	NULL
K.	NULL
,	NULL
Pape	NULL
,	NULL
G.	NULL
R.	NULL
,	NULL
Riethmiiller	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
Weiss	NULL
,	NULL
E.	NULL
H.	NULL
(	NULL
1991	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

173	NULL
,	NULL
209-219	NULL
Nordeen	NULL
,	NULL
S.	NULL
K.	NULL
(	NULL
1988	NULL
)	NULL
BioTechniques	NULL
6	NULL
,	NULL
454-457	NULL
Bachelerie	NULL
,	NULL
F.	NULL
,	NULL
Alcami	NULL
,	NULL
J.	NULL
,	NULL
Arenzana-Seisdedos	NULL
,	NULL
F.	NULL
,	NULL
and	NULL
Virelizier	NULL
,	NULL
J.	NULL
L.	NULL
(	NULL
1991	NULL
)	NULL
Nature	NULL
350	NULL
,	NULL
709-712	NULL
Ziegler-Heitbrock	NULL
,	NULL
H.	NULL
W.	NULL
L.	NULL
,	NULL
Blumenstein	NULL
,	NULL
M.	NULL
,	NULL
Kéfferlein	NULL
,	NULL
E.	NULL
,	NULL
Kieper	NULL
,	NULL
D.	NULL
,	NULL
Petersmann	NULL
,	NULL
L.	NULL
,	NULL
Endres	NULL
,	NULL
S.	NULL
,	NULL
Flegel	NULL
,	NULL
W.	NULL
,	NULL
Northoff	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
Haas	NULL
,	NULL
J.	NULL
G.	NULL
(	NULL
1992	NULL
)	NULL
Immunology	NULL
75	NULL
,	NULL
264-268	NULL
Wright	NULL
,	NULL
S.	NULL
D.	NULL
,	NULL
Ramos	NULL
,	NULL
R.	NULL
A.	NULL
,	NULL
Tobias	NULL
,	NULL
P.	NULL
S.	NULL
,	NULL
Ulevitch	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
and	NULL
Mathison	NULL
,	NULL
J.	NULL
C.	NULL
(	NULL
1990	NULL
)	NULL
Science	NULL
249	NULL
,	NULL
1431-1433	NULL
Ziegler-Heitbrock	NULL
,	NULL
H.	NULL
W.	NULL
L.	NULL
,	NULL
and	NULL
Ulevitch	NULL
,	NULL
R.	NULL
J	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Immunol	NULL
.	NULL

Today	NULL
14	NULL
,	NULL
121-125	NULL
Labeta	NULL
,	NULL
M.	NULL
O.	NULL
,	NULL
Durieux	NULL
,	NULL
J.-J	NULL
.	NULL

,	NULL
Spagnoli	NULL
,	NULL
G.	NULL
,	NULL
Fernandez	NULL
,	NULL
N.	NULL
,	NULL
and	NULL
Herrmann	NULL
,	NULL
R.	NULL
(	NULL
1993	NULL
)	NULL
Immunology	NULL
80	NULL
,	NULL
415-423	NULL
Miller	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Ziegler-Heitbrock	NULL
,	NULL
H.	NULL
W.	NULL
L.	NULL
,	NULL
and	NULL
Bauerle	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Immuno-biology	NULL
187	NULL
,	NULL
233-256	NULL
Haas	NULL
,	NULL
J.	NULL
G.	NULL
,	NULL
Biuerle	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
Riethmiiller	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
Ziegler-Heitbrock	NULL
,	NULL
H.	NULL
W.	NULL
L.	NULL
(	NULL
1990	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

87	NULL
,	NULL
9563-9567	NULL
Kaufman	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
Weinberg	NULL
,	NULL
J	NULL
.	NULL

B.	NULL
,	NULL
and	NULL
Greene	NULL
,	NULL
W.	NULL
C.	NULL
(	NULL
1992	NULL
)	NULL
J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

90	NULL
,	NULL
121-129	NULL
Kang	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
Tran	NULL
,	NULL
A.-C.	NULL
,	NULL
Grilli	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Lenardo	NULL
,	NULL
M.	NULL
J	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Science	NULL
256	NULL
,	NULL
1452-1456	NULL
Schmitz	NULL
,	NULL
M.	NULL
L.	NULL
,	NULL
and	NULL
Béuerle	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

10	NULL
,	NULL
3805-3817	NULL
Henkel	NULL
,	NULL
T.	NULL
,	NULL
Zabel	NULL
,	NULL
U.	NULL
,	NULL
van	NULL
Zee	NULL
,	NULL
K.	NULL
,	NULL
Miller	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Fanning	NULL
,	NULL
E.	NULL
,	NULL
and	NULL
Biuerle	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Cell	NULL
68	NULL
,	NULL
1121-1133	NULL
Franzoso	NULL
,	NULL
G.	NULL
,	NULL
Bours	NULL
,	NULL
V.	NULL
,	NULL
Park	NULL
,	NULL
S.	NULL
,	NULL
Tomita-Yamaguchi	NULL
,	NULL
M.	NULL
,	NULL
Kelly	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Siebenlist	NULL
,	NULL
U	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Nature	NULL
859	NULL
,	NULL
339-342	NULL
Cogswell	NULL
,	NULL
P.	NULL
C.	NULL
,	NULL
Scheinman	NULL
,	NULL
R.	NULL
I.	NULL
,	NULL
and	NULL
Baldwin	NULL
,	NULL
A.	NULL
S.	NULL
,	NULL
Jr.	NULL
(	NULL
1993	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

150	NULL
,	NULL
2794-2804	NULL
Ten	NULL
,	NULL
R.	NULL
M.	NULL
,	NULL
Paya	NULL
,	NULL
C.	NULL
V.	NULL
,	NULL
Israel	NULL
,	NULL
N.	NULL
,	NULL
LeBail	NULL
,	NULL
O.	NULL
,	NULL
Mattei	NULL
,	NULL
M.-G.	NULL
,	NULL
Virelizier	NULL
,	NULL
J.-L.	NULL
,	NULL
Kourilsky	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Israel	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

11	NULL
,	NULL
195-203	NULL
Ueberla	NULL
,	NULL
K.	NULL
,	NULL
Lu	NULL
,	NULL
Y.	NULL
,	NULL
Chung	NULL
,	NULL
E.	NULL
,	NULL
and	NULL
Haseltine	NULL
,	NULL
W.	NULL
A	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
J	NULL
.	NULL

Acquired	NULL
Immune	NULL
Defic	NULL
.	NULL

Syndr	NULL
.	NULL

6	NULL
,	NULL
227-230	NULL
Israel	NULL
,	NULL
A.	NULL
,	NULL
Kimura	NULL
,	NULL
A.	NULL
,	NULL
Kieran	NULL
,	NULL
M.	NULL
,	NULL
Yano	NULL
,	NULL
O.	NULL
,	NULL
Kanellopoulus	NULL
,	NULL
J.	NULL
,	NULL
LeBail	NULL
,	NULL
O.	NULL
,	NULL
and	NULL
Kourilsky	NULL
,	NULL
P.	NULL
(	NULL
1987	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

84	NULL
,	NULL
2653-2657	NULL
Fujita	NULL
,	NULL
T.	NULL
,	NULL
Nolan	NULL
,	NULL
G.	NULL
P.	NULL
,	NULL
Ghosh	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1992	NULL
)	NULL
Genes	NULL
&	NULL
Dev	NULL
.	NULL

6	NULL
,	NULL
775-1787	NULL
Fujita	NULL
,	NULL
T.	NULL
,	NULL
Nolan	NULL
,	NULL
G.	NULL
P.	NULL
,	NULL
Liou	NULL
,	NULL
H.	NULL
C.	NULL
,	NULL
Scott	NULL
,	NULL
M.	NULL
L.	NULL
,	NULL
and	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1993	NULL
)	NULL
Genes	NULL
&	NULL
Dev	NULL
.	NULL

7	NULL
,	NULL
1354-1363	NULL
Bours	NULL
,	NULL
V.	NULL
,	NULL
Franzoso	NULL
,	NULL
G.	NULL
,	NULL
Azarenko	NULL
,	NULL
V.	NULL
,	NULL
Park	NULL
,	NULL
S.	NULL
,	NULL
Kanno	NULL
,	NULL
T.	NULL
,	NULL
Brown	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Siebenlist	NULL
,	NULL
U	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Cell	NULL
72	NULL
,	NULL
729-739	NULL
Ziegler-Heitbrock	NULL
,	NULL
H.	NULL
W.	NULL
L.	NULL
,	NULL
Schraut	NULL
,	NULL
W.	NULL
,	NULL
Wendelgass	NULL
,	NULL
P.	NULL
,	NULL
Strobel	NULL
,	NULL
M.	NULL
,	NULL
Sternsdorf	NULL
,	NULL
T.	NULL
,	NULL
Weber	NULL
,	NULL
C.	NULL
,	NULL
Aepfelbacher	NULL
,	NULL
M.	NULL
,	NULL
Weber	NULL
,	NULL
P.	NULL
C.	NULL
,	NULL
Ehlers	NULL
,	NULL
M.	NULL
,	NULL
Schiitt	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Haas	NULL
,	NULL
J.	NULL
G.	NULL
(	NULL
1994	NULL
)	NULL
J.	NULL
Leukocyte	NULL
Biol	NULL
.	NULL

55	NULL
,	NULL
73-80	NULL

